Oh, what a time to be alive! After a mere thirty years of scratching our heads, the elusive sigma 2 receptor (σ₂R), also known as the ever-so-catchy transmembrane protein 97 (TMEM97), has finally been pinned down. And guess what? It turns out that this little rascal might just be the key to soothing that pesky neuropathic pain that’s been bothering mice (and presumably humans).

So, our intrepid researchers, armed with their lab coats and pipettes, set out to answer two earth-shattering questions: First, do these σ₂R/TMEM97-targeting wonder drugs actually need the receptor to work their magic? And second, what’s the secret sauce behind their ability to tell those overzealous pain neurons to take a chill pill?

Enter the knockout mice, the unsung heroes of science, who graciously gave up their TMEM97 genes for the cause. Lo and behold, without TMEM97, the compound FEM-1689 couldn’t do its thing, proving that yes, you indeed need the receptor for the pain relief party.

But wait, there’s more! It turns out FEM-1689 is like the cool teacher who tells the neurons’ integrated stress response (ISR) to relax, and even encourages them to grow some new neurites. And because we’re all about inclusivity, these findings aren’t just for mice; human sensory neurons also get to join the fun, with FEM-1689 telling their ISR to take a hike, too.

And for the grand finale, the researchers found that this σ₂R/TMEM97 character is hanging out in human pain-sensing cells and their glial entourage, making it a hot new target for the neuropathic pain relief fan club.

In conclusion, σ₂R/TMEM97, you’re not just a mouthful to say, you’re also a beacon of hope for all those looking to kick neuropathic pain to the curb. Bravo, science, bravo! 🎉